CYCLO THERAPEUTICS, INC. Proceeds from Stock Options Exercised
CYCLO THERAPEUTICS, INC. reported Proceeds from Stock Options Exercised of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2024-12-18
- CYCLO THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2023-12-31 was $0.00.
- CYCLO THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2022-12-31 was $0.00.
- CYCLO THERAPEUTICS, INC. proceeds from stock options exercised for fiscal 2023 was $1.48K.
- CYCLO THERAPEUTICS, INC. proceeds from stock options exercised for fiscal 2022 was $0.00.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | ||
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-18 | $1.48K 10-K/A · filed 2024-12-18 | |
| 2023-09-30 | $1.48K 10-Q · filed 2024-11-14 | ||
| 2022-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-18 | $0.00 10-K/A · filed 2024-12-18 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-14 |